|
| December 3, 2017 | |
| |
| The latest prostate cancer news from News Medical | |
|
|
|
|
![](https://blogger.googleusercontent.com/img/proxy/AVvXsEijV7MIkXh00rOZ_R5qVHH1JKfkthSVtwsx_HwOZUf9PO62_c9RlbMw4vS34QCX21Cv-Uz5yieQnZK66WXWyUjk72gw1enRM2PSmyfFkw1-YP7Q1741dxNAtdRe7djUd3N7f7jajuBv5KByY67duukw9TRdWHfmv8Pml-KoWTYcIjtCGI6yzgkdGz8ghbbyF-wOK-mBADRa4XJg=s0-d-e1-ft) |
|
Protein and peptide microarrays, the emerging tools for proteomics and clinical assays, are high-throughput methods that track binding events and activities, and decide the function of proteins on a large scale. Microarrays find their place in epitope mapping and serodiagnostic applications. | |
|
|
Compared with the non-Hispanic white population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer. | |
|
|
|
|
No hay comentarios:
Publicar un comentario